Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
(ACER) $2.60--GREAT News
Relief Therapeutics Holding AG: RELIEF THERAPEUTICS Holdings AG: Acer Therapeutics and Relief Therapeutics Announce Submission of a New Drug Application to the U.S. FDA for ACER-001 for Treatment of Urea Cycle Disorders
https://www.finanznachrichten.de/nachrichten-2021-08/53627131-relief-therapeutics-holding-ag-relief-therapeutics-holdings-ag-acer-therapeutics-and-relief-therapeutics-announce-submission-of-a-new-drug-applicati-200.htm
(ACOGf) $0.73-PHASE 3 Alzheimer Drug with data readout expected during Q1 2022 / its a new listed company from canada so its still UNKNOWN .this one could be more than just a 10 bagger just look at the performance of SAVA and ANVS which are Alzheimer gems too .
Alpha-1062 Could Become A Best In Class Treatment Option for Patients Suffering from Alzheimer's Disease
https://www.benzinga.com/general/biotech/21/07/22140880/alpha-cognition-is-a-clinical-stage-biopharmaceutical-company-dedicated-to-developing-treatments-
ACER about to BREAKOUT ...imminent NDA submission expected within 4 weeks
ACER $2.50 next Breakout gem ? NDA submission imminent ,marketcap only 34 million
(CDTX) $1.78 movingggin premkt..this dirt cheap biotech company trading around cash level and are close to release Phase 3 results in Q4 .they have 2 big partnerships with Janssen Pharma and Mundipharma worth $1.3 billion ..check out their presentation
Presentation
https://ir.cidara.com/static-files/2e04fdaf-6edd-47e8-8644-78ee106eb3b6
(ACER) $2.33--low float biotech with imminent NDA filing expected during this quarter
CDTX $1.80 could hit $2 today ...has low valuation of $80 million while cash balance is around $75 million / BIG Phase 3 readout expected next quarter so this brutally underpriced biotech could runup in the coming weeks
(ETTX) $2.23 -BIG Phase 3 data in October ,low priced and well financed biotech with 2x PHASE 3 Assets
(CDTX) $1.52-MC $73 m trading at Cash plus PHASE 3 readout expected next Quarter / has 2 BIG Pharma Deals in place worth $1.3 BILLION ..has everything to be the next 10 bagger ..more informations in the new presentation .
Presentation
https://ir.cidara.com/static-files/2e04fdaf-6edd-47e8-8644-78ee106eb3b6
(MRM)MC 38 m-Float 2 m next low float bomb to EXPLODE ..stock is under radar and underpriced
Fed mafia CANT stop printing because everything would collapse ,what do you think who is buying all those bonds of the bankrupt US State ?
(MRM) MC 38m-float 2m-attractive company which is close to profitability ...
https://medirom.co.jp/en/services
ERYP up 100% after fast track news ,,high was 22 bucks
(VLON)very attractive &low priced biotech see my previos posting
VLON $4.70 RALLYYYYYYYYYYYYYYYYYYYY
RVPH breakoutttttt